1. Home
  2. PCB vs SPRY Comparison

PCB vs SPRY Comparison

Compare PCB & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$28.67

Market Cap

389.5M

Sector

Finance

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$4.05

Market Cap

415.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCB
SPRY
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
389.5M
415.7M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
PCB
SPRY
Price
$28.67
$4.05
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
★ $30.50
$22.50
AVG Volume (30 Days)
45.2K
★ 1.4M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 3.06%
N/A
EPS Growth
★ 48.28
N/A
EPS
★ 1.47
N/A
Revenue
$2,899,000.00
★ $84,278,000.00
Revenue This Year
$7.98
$52.57
Revenue Next Year
$7.00
$45.52
P/E Ratio
$19.55
★ N/A
Revenue Growth
★ 4.51
N/A
52 Week Low
$20.78
$3.81
52 Week High
$30.84
$13.15

Technical Indicators

Market Signals
Indicator
PCB
SPRY
Relative Strength Index (RSI) 61.12 41.52
Support Level $27.14 $3.91
Resistance Level $28.84 $4.60
Average True Range (ATR) 0.67 0.25
MACD 0.10 0.05
Stochastic Oscillator 72.61 27.26

Price Performance

Historical Comparison
PCB
SPRY

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: